Cryo-Cell International Profit Margin

The latest profit margin for CCEL is -7.92% as of May 2026. That compares with -0.54% in the prior-year period — down 1379.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Cryo-Cell International's historical trend and sector peers before judging valuation or financial health.

Over the past year, CCEL's profit margin moved from -0.54% to -7.92% — a 1379.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cryo-Cell International's valuation or profitability profile.

Against Healthcare companies, CCEL currently prints -7.92% for profit margin, while the sector average sits near 13.89%. That is roughly 157.1% below the sector mean. Large gaps often invite a closer look at Cryo-Cell International's growth, margins, and balance sheet.

Profit Margin shows how effectively Cryo-Cell International converts resources into returns. At -7.92%, CCEL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -0.54% in the prior-year period — down 1379.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CCEL's profit margin (-7.92%), review year-over-year change from -0.54%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.